Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01379781 · ClinicalTrials.gov registry record · NA
Behavioral Change in the Mother-Infant Dyad: Preventing Postpartum Depression
A NA study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
NCT01379781: Completed NA study, sponsored by New York State Psychiatric Institute.
NCT01379781 is a NA study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 54 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01379781, a NA study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
Study Summary
Postpartum depression (PPD) is undertreated and the consequences of this are substantial for women and children. Studies show that infant cry/fuss and sleep behavior are associated with PPD, and that parenting interventions can change infant behavior, yet these findings have never been applied to PPD. In this study, the investigators are teaching parenting skills to increase infant nocturnal sleep and reduce fuss/cry behavior to women likely to develop PPD to see if the investigators can prevent the onset of this disorder.
Primary Outcome
* Assessing severity of depression; clinician rated * 24 questions * 13 items are scored on a 5 point scale ranging from 0=not present to 4=severe * 11 items are scored from 0-2 * A composite score is created by the sum of the scores from all items. Scores can range from 0-74 * 0-7: normal * 8-13: mild depression * 14-18: moderate depression * 19-23: severe depression * 24: very severe depression * Higher summed values indicate a greater severity of depression
Interventions
- BEHAVIORAL Behavioral Intervention for PPD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2011-08 |
| Est. Completion | 2018-02 |
| Phase | NA |
What the finished NCT01379781 record still lists
NCT01379781 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Behavioral Intervention for PPD is the first listed.
NCT01379781 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01379781 about?
NCT01379781 is a clinical study titled "Behavioral Change in the Mother-Infant Dyad: Preventing Postpartum Depression". Postpartum depression (PPD) is undertreated and the consequences of this are substantial for women and children. Studies show that infant cry/fuss and sleep behavior are associated with PPD, and that parenting interventions can change infant behavior, yet these findings have never been applied to PP...
What is the current status of trial NCT01379781?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2011-08. Estimated completion is 2018-02.
What interventions are being tested in trial NCT01379781?
The interventions under investigation include: Behavioral Intervention for PPD (BEHAVIORAL).
Who is sponsoring clinical trial NCT01379781?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01379781's enrollment target sits among peer trials
54 1268th of 2000 higher than 730 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia